Glenmark Therapeutics Launches Polyethylene Glycol 3350 Powder for Solution

Glenmark Therapeutics Inc. has launched Polyethylene Glycol 3350 Powder for Solution, an osmotic laxative used to treat constipation. This product is available over-the-counter and works by increasing water in the stool to induce bowel movements. Glenmark's expansion into this market aligns with its strategy to offer affordable healthcare solutions. Meanwhile, Glenmark Pharmaceuticals Ltd. continues to focus on its injectable portfolio in the US, recently launching Acetylcysteine Injection.

 

Source: Glenmark Pharmaceuticals, NSE, BSE